1. Home
  2. NERV vs PT Comparison

NERV vs PT Comparison

Compare NERV & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • PT
  • Stock Information
  • Founded
  • NERV 2007
  • PT 2012
  • Country
  • NERV United States
  • PT China
  • Employees
  • NERV N/A
  • PT N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • NERV Health Care
  • PT Technology
  • Exchange
  • NERV Nasdaq
  • PT Nasdaq
  • Market Cap
  • NERV 14.6M
  • PT 14.7M
  • IPO Year
  • NERV 2014
  • PT 2018
  • Fundamental
  • Price
  • NERV $3.73
  • PT $1.02
  • Analyst Decision
  • NERV Hold
  • PT
  • Analyst Count
  • NERV 1
  • PT 0
  • Target Price
  • NERV $4.00
  • PT N/A
  • AVG Volume (30 Days)
  • NERV 8.7M
  • PT 92.8K
  • Earning Date
  • NERV 11-05-2025
  • PT 09-19-2025
  • Dividend Yield
  • NERV N/A
  • PT N/A
  • EPS Growth
  • NERV N/A
  • PT N/A
  • EPS
  • NERV N/A
  • PT N/A
  • Revenue
  • NERV N/A
  • PT $4,961,892.00
  • Revenue This Year
  • NERV N/A
  • PT N/A
  • Revenue Next Year
  • NERV N/A
  • PT N/A
  • P/E Ratio
  • NERV N/A
  • PT N/A
  • Revenue Growth
  • NERV N/A
  • PT 9.20
  • 52 Week Low
  • NERV $1.15
  • PT $0.76
  • 52 Week High
  • NERV $12.46
  • PT $1.38
  • Technical
  • Relative Strength Index (RSI)
  • NERV 51.45
  • PT 58.21
  • Support Level
  • NERV $3.50
  • PT $0.93
  • Resistance Level
  • NERV $4.00
  • PT $1.06
  • Average True Range (ATR)
  • NERV 0.95
  • PT 0.06
  • MACD
  • NERV -0.13
  • PT 0.01
  • Stochastic Oscillator
  • NERV 11.92
  • PT 79.73

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: